MedWatch Technologies, Inc. – Trademark Portfolio

Entity Type: 03

MedWatch Technologies, Inc. holds 4 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 9 (Computers & Electronics) — 4 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 3 Nice Classification classes. Currently, 0 trademarks are registered and 3 are pending. The owner is based in Las Vegas, NV.

8304 Mount Logan Court

Las Vegas, NV 89131

4 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

VAIA
VAIA
Pending 2025
SAIGE
SAIGE
Pending 2025

Trademark Classifications

MedWatch Technologies, Inc.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

9
Computers & Electronics (4 filings)

Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments

42
Computer & Scientific (3 filings)

Scientific and technological services; industrial analysis and research services

10
Medical Apparatus (2 filings)

Surgical, medical, dental and veterinary apparatus and instruments

Frequently Asked Questions

How many trademarks does MedWatch Technologies, Inc. have?

MedWatch Technologies, Inc. has 4 U.S. trademarks filed with the USPTO. Of these, 3 pending, 1 abandoned.

What trademark classes does MedWatch Technologies, Inc. file in?

MedWatch Technologies, Inc. files trademarks across 3 Nice Classification classes. The most active classes are Class 9 (Computers & Electronics), Class 42 (Computer & Scientific), Class 10 (Medical Apparatus). Class 9 covers scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments.

What is MedWatch Technologies, Inc.'s trademark registration success rate?

MedWatch Technologies, Inc. has a 0% trademark registration rate, with 0 out of 1 resolved applications resulting in successful registration. Currently, 3 applications are pending review.